Finally, an association between metastatic suppression and miR-335 expression targeting the ECM component tenascin C encoding gene (TNC) was observed by examining other structural ECM proteins including glycosaminoglycans, proteoglycans, and matricellular proteins [124], and the loss of miR-335 was detected in BC patients with poor prognosis [133]. The gene discussed is TNC; the disease is breast cancer.